A 67-year-old man with acute anterolateral myocardial infarction had recurrent ventricular fibrillation that required insertion of temporary pacemaker. When a permanent pacemaker was inserted stable ...
Patients who require a new permanent pacemaker after TAVI do just as well with leadless devices out to 2 years as they do with transvenous pacemakers, according to an analysis of real-world data from ...
An indication for a pacemaker or implantable cardioverter-defibrillator (ICD) in a patient with an intracardiac shunt requires a balancing of the risks and benefits associated with a transvenous ...
(HealthDay)—The incidence of complications for single- and dual-chamber transvenous pacemakers (TVPs) is considerable, reaching about 15 and 16 percent, respectively, by three years, with high ...
One of the largest and longest follow-ups of patients implanted with the subcutaneous-lead implantable cardioverter defibrillator (S-ICD), now marketed as the EMBLEM S-ICD (Boston Scientific), paints ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Complications related to transvenous pacemakers have ...
In a typical population of patients requiring implantable cardioverter-defibrillator (ICD) therapy without pacing, mostly for the primary prevention of sudden cardiac death, a subcutaneous ICD (S-ICD; ...
As FDA considers leadless pacemakers, Boston Scientific is developing a new entry that could be used in coordination with its subcutaneous S-ICD. Here's the latest on that device. Marie Thibault ...
Leadless pacemakers and implantable cardioverter defibrillators (ICDs) are expected to deliver a welcome jolt to the cardiac rhythm management (CRM) market in the coming years owing to their small ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results